Information:
Fel:
ID
31404
Beskrivning
Interleukin-1 Receptor Antagonist and Insulin Sensitivity; ODM derived from: https://clinicaltrials.gov/show/NCT00928876
Länk
https://clinicaltrials.gov/show/NCT00928876
Nyckelord
Versioner (1)
- 2018-08-19 2018-08-19 -
Rättsinnehavare
see clinicaltrials.gov
Uppladdad den
19 augusti 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT00928876
Eligibility Diabetes Mellitus, Type 2 NCT00928876
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00928876
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Adult | Body mass index
Item
adult subjects with a bmi > 30 kg/m2
boolean
C0001675 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
C1305855 (UMLS CUI [2])
Metabolic Syndrome X; Characteristics
Item
3 or more characteristics of the metabolic syndrome
boolean
C0524620 (UMLS CUI [1,1])
C1521970 (UMLS CUI [1,2])
C1521970 (UMLS CUI [1,2])
Informed consent
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus
Item
known diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Plasma fasting glucose measurement | Glycosylated hemoglobin A
Item
fasting plasma glucose > 7,0 mmol/l or hba1c > 6,2%
boolean
C0583513 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
C0019018 (UMLS CUI [2])
Condition; Interferes with; Study Protocol
Item
presence of any medical condition that might interfere with the current study protocol
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Therapeutic immunosuppression; Immunologic Deficiency Syndromes
Item
immunodeficiency of immunosuppressive treatment
boolean
C0021079 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
C0021051 (UMLS CUI [1,2])
Anti-Inflammatory Agents | Aspirin
Item
anti-inflammatory drugs (100 mg of aspirin/day is allowed)
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
C0004057 (UMLS CUI [2])
Infection; Current (present time)
Item
signs of current infection
boolean
C3714514 (UMLS CUI [1,1])
C0521116 (UMLS CUI [1,2])
C0521116 (UMLS CUI [1,2])
Infection; Recurrent
Item
history of recurrent infections
boolean
C3714514 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
C2945760 (UMLS CUI [1,2])
Pregnancy; Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Liver diseases
Item
liver disease
boolean
C0023895 (UMLS CUI [1])
Kidney Diseases
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Neutropenia
Item
neutropenia
boolean
C0027947 (UMLS CUI [1])